RhumbLine Advisers
TENX icon

RhumbLine Advisers’s Tenax Therapeutics TENX Stock Holding History

RhumbLine Advisers’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Buy
+31,291
New +$400K ﹤0.01% 2835

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

RhumbLine Advisers's TENX Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 31,291 shares worth $455K. The stake represents ﹤0.01% of the portfolio and ranks #2835 among its holdings.

30 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • RhumbLine Advisers held 31,291 shares of Tenax Therapeutics worth $455K as of Q2 2026.
  • Tenax Therapeutics was a new RhumbLine Advisers position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2835 holding.
  • 30 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.